| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| GRANISETRON
| GRANISETRON | METABOLISM | INJECTION ORAL TRANSDERMAL SUBCUTANEOUS | Cmax 206 NANOMOLAR VD 197 LITER (65 KILOGRAM) PPB 65 PERCENT Cl 51.3 LITER / HOUR (65 KILOGRAM) HT 4.9 HOUR SOLUBILITY READILY SOLUBLE IN WATER | 5-HYDROXYTRYPTAMINE 3 RECEPTOR PDB 2YME (CRYSTAL STRUCTURE OF A MUTANT BINDING PROTEIN (5HTBP-ACHBP) IN COMPLEX WITH GRANISETRON) LIGAND CODE = CWB (link to the list of PDB complexes) Download experimental 3D coordinates of CWB with added hydrogens | 5-hydroxytryptamine receptor 3A UNIPROT P46098 HTR3A more at DrugCentral | EMA | |||
